Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-24
2011-05-24
Moore, Susanna (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S281000
Reexamination Certificate
active
07947689
ABSTRACT:
The invention relates to pyrazolopyrimidine derivatives of formula (I)whereinY1, Y2and Y3independently are e.g. CR10, NH, S or O,whereby at least one of Y1, Y2and Y3represents CR10;R1represents chloro or bromo;R2, R3, R4, R5, R6and R7represent e.g. hydrogen or C1-C6-alkyl, andR10represents e.g. hydrogen, halogen or phenyl;which are potent mGluR5 modulators and are e.g. useful for the treatment of various neurological disorders.
REFERENCES:
patent: 5037834 (1991-08-01), Brighty et al.
patent: 6177443 (2001-01-01), Madsen et al.
patent: 6498251 (2002-12-01), Kikuchi et al.
patent: 6573381 (2003-06-01), Bousquet et al.
patent: 2006/0089362 (2006-04-01), Seno et al.
patent: 99/26927 (1999-06-01), None
patent: 00/12074 (2000-03-01), None
patent: 02/088088 (2002-11-01), None
patent: 03/037900 (2003-05-01), None
patent: 03/091256 (2003-11-01), None
patent: 03/101993 (2003-12-01), None
patent: 2004/087153 (2004-10-01), None
patent: 2004/089415 (2004-10-01), None
patent: 2004/089416 (2004-10-01), None
patent: 2004/089471 (2004-10-01), None
patent: 2005/121175 (2005-12-01), None
patent: 2006/015737 (2006-02-01), None
patent: 2006/077401 (2006-07-01), None
Vippagunta, S.R., Adv. Drug. Delivery Rev., 2001, 48, p. 3-26.
Netterwald, J., Drug Discovery and Dev., 2007, 9(9), p. 22-26.
G. Hajos, et al., “Product class 5: Azaindolizines with two nitrogen atoms in the five-membered ring” Science of Synthesis, Vo. 109, p. 613-678, 2002.
Laura Bettinetti, “Solution and solid phase supported synthesis of 7a-Azaindoles as novel subtype selective dopamine receptor ligands” Ph. D. Thesis, University of Erlangen, Germanyy 2004.
ChemBridge Corporation: Registry No. 833441-66-0; of Feb. 18, 2005.
DE102004037445, Mar. 16, 2006, Abstract.
International Search Report for PCT/EP2007/058061 of Dec. 3, 2007.
Database CHEMCATS, XP 002460679, Accession No. 2033272150, 2007.
Danysz Wojciech
Dekundy Andrzej
Fotins Juris
Gutcaits Aleksandrs
Hechenberger Mirko
Hueschen and Sage
Merz Pharma GmbH & Co. KGaA
Moore Susanna
LandOfFree
Substituted pyrazolo[1,5-a]pyrimidines as metabotropic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazolo[1,5-a]pyrimidines as metabotropic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazolo[1,5-a]pyrimidines as metabotropic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2635516